Meanwhile on Monday, another leading telehealth player, Noom, announced a GLP-1 microdosing program, priced from $119 to $199 a month, which it said would minimize semaglutide side effects
Policy discussions reinforced that FIM does not exist in isolation
The regulatory team, manufacturing infrastructure, and commercial playbook are already in place
Knowing when to use or discard your medication ensures your weight loss progress remains safe and effective
The price at the pharmacy stays the same, but using pre-tax dollars effectively lowers your real cost
The cost difference comes from eliminating branded packaging, marketing expenses, and pharmaceutical company profit margins